Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market - Global Outlook and Forecast 2022-2028

February 2022 | 65 pages | ID: A6935EFE2ABEEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs in Global, including the following market information:

Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Agonist Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs include Roche, Regeneron Pharmaceuticals, Bayer, Santen Oy, Kanghong Pharmaceuticals, Novartis, Eli Lilly and Company, TRACON Pharmaceuticals and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Segment Percentages, by Type, 2021 (%)

• Agonist
• Allosteric Modulator
• Kinase Inhibitor
• Monoclonal Antibody
• Others

Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Regeneron Pharmaceuticals
• Bayer
• Santen Oy
• Kanghong Pharmaceuticals
• Novartis
• Eli Lilly and Company
• TRACON Pharmaceuticals
• Pfizer
• GSK
• BIOCAD

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR (ANTI-VEGF) DRUGS OVERALL MARKET SIZE

2.1 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size: 2021 VS 2028
2.2 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Players in Global Market
3.2 Top Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Companies Ranked by Revenue
3.3 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Markets, 2021 & 2028
  4.1.2 Agonist
  4.1.3 Allosteric Modulator
  4.1.4 Kinase Inhibitor
  4.1.5 Monoclonal Antibody
  4.1.6 Others
4.2 By Type - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue & Forecasts
  4.2.1 By Type - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue & Forecasts
  5.2.1 By Application - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2021 & 2028
6.2 By Region - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue & Forecasts
  6.2.1 By Region - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2017-2028
  6.3.2 US Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2017-2028
  6.3.3 Canada Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2017-2028
  6.3.4 Mexico Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2017-2028
  6.4.2 Germany Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2017-2028
  6.4.3 France Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2017-2028
  6.4.4 U.K. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2017-2028
  6.4.5 Italy Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2017-2028
  6.4.6 Russia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2017-2028
  6.4.8 Benelux Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2017-2028
  6.5.2 China Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2017-2028
  6.5.3 Japan Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2017-2028
  6.5.4 South Korea Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2017-2028
  6.5.6 India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2017-2028
  6.6.2 Brazil Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2017-2028
  6.6.3 Argentina Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2017-2028
  6.7.2 Turkey Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2017-2028
  6.7.3 Israel Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2017-2028
  6.7.5 UAE Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings
  7.1.4 Roche Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global Market (2017-2022)
  7.1.5 Roche Key News
7.2 Regeneron Pharmaceuticals
  7.2.1 Regeneron Pharmaceuticals Corporate Summary
  7.2.2 Regeneron Pharmaceuticals Business Overview
  7.2.3 Regeneron Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings
  7.2.4 Regeneron Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global Market (2017-2022)
  7.2.5 Regeneron Pharmaceuticals Key News
7.3 Bayer
  7.3.1 Bayer Corporate Summary
  7.3.2 Bayer Business Overview
  7.3.3 Bayer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings
  7.3.4 Bayer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global Market (2017-2022)
  7.3.5 Bayer Key News
7.4 Santen Oy
  7.4.1 Santen Oy Corporate Summary
  7.4.2 Santen Oy Business Overview
  7.4.3 Santen Oy Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings
  7.4.4 Santen Oy Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global Market (2017-2022)
  7.4.5 Santen Oy Key News
7.5 Kanghong Pharmaceuticals
  7.5.1 Kanghong Pharmaceuticals Corporate Summary
  7.5.2 Kanghong Pharmaceuticals Business Overview
  7.5.3 Kanghong Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings
  7.5.4 Kanghong Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global Market (2017-2022)
  7.5.5 Kanghong Pharmaceuticals Key News
7.6 Novartis
  7.6.1 Novartis Corporate Summary
  7.6.2 Novartis Business Overview
  7.6.3 Novartis Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings
  7.6.4 Novartis Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global Market (2017-2022)
  7.6.5 Novartis Key News
7.7 Eli Lilly and Company
  7.7.1 Eli Lilly and Company Corporate Summary
  7.7.2 Eli Lilly and Company Business Overview
  7.7.3 Eli Lilly and Company Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings
  7.7.4 Eli Lilly and Company Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global Market (2017-2022)
  7.7.5 Eli Lilly and Company Key News
7.8 TRACON Pharmaceuticals
  7.8.1 TRACON Pharmaceuticals Corporate Summary
  7.8.2 TRACON Pharmaceuticals Business Overview
  7.8.3 TRACON Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings
  7.8.4 TRACON Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global Market (2017-2022)
  7.8.5 TRACON Pharmaceuticals Key News
7.9 Pfizer
  7.9.1 Pfizer Corporate Summary
  7.9.2 Pfizer Business Overview
  7.9.3 Pfizer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings
  7.9.4 Pfizer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global Market (2017-2022)
  7.9.5 Pfizer Key News
7.10 GSK
  7.10.1 GSK Corporate Summary
  7.10.2 GSK Business Overview
  7.10.3 GSK Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings
  7.10.4 GSK Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global Market (2017-2022)
  7.10.5 GSK Key News
7.11 BIOCAD
  7.11.1 BIOCAD Corporate Summary
  7.11.2 BIOCAD Business Overview
  7.11.3 BIOCAD Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings
  7.11.4 BIOCAD Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global Market (2017-2022)
  7.11.5 BIOCAD Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Opportunities & Trends in Global Market
Table 2. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Drivers in Global Market
Table 3. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Restraints in Global Market
Table 4. Key Players of Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs in Global Market
Table 5. Top Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Type
Table 9. List of Global Tier 1 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings
Table 32. Roche Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Regeneron Pharmaceuticals Corporate Summary
Table 34. Regeneron Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings
Table 35. Regeneron Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Bayer Corporate Summary
Table 37. Bayer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings
Table 38. Bayer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Santen Oy Corporate Summary
Table 40. Santen Oy Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings
Table 41. Santen Oy Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Kanghong Pharmaceuticals Corporate Summary
Table 43. Kanghong Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings
Table 44. Kanghong Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings
Table 47. Novartis Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Eli Lilly and Company Corporate Summary
Table 49. Eli Lilly and Company Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings
Table 50. Eli Lilly and Company Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), (2017-2022)
Table 51. TRACON Pharmaceuticals Corporate Summary
Table 52. TRACON Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings
Table 53. TRACON Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings
Table 56. Pfizer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), (2017-2022)
Table 57. GSK Corporate Summary
Table 58. GSK Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings
Table 59. GSK Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), (2017-2022)
Table 60. BIOCAD Corporate Summary
Table 61. BIOCAD Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings
Table 62. BIOCAD Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Segment by Type in 2021
Figure 2. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Segment by Application in 2021
Figure 3. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in 2021
Figure 8. By Type - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2017-2028
Figure 12. US Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2017-2028
Figure 24. China Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Regeneron Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bayer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Santen Oy Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Kanghong Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Eli Lilly and Company Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. TRACON Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. GSK Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. BIOCAD Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)